/PRNewswire/ NVX-CoV2373 is the first protein-based COVID-19 vaccine authorized in multiple major markets around the world, including the European Union,.
Novavax Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights novavax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from novavax.com Daily Mail and Mail on Sunday newspapers.